ZA915012B - Pyridopyrazine derivatives for treating substance abuse and addiction - Google Patents

Pyridopyrazine derivatives for treating substance abuse and addiction

Info

Publication number
ZA915012B
ZA915012B ZA915012A ZA915012A ZA915012B ZA 915012 B ZA915012 B ZA 915012B ZA 915012 A ZA915012 A ZA 915012A ZA 915012 A ZA915012 A ZA 915012A ZA 915012 B ZA915012 B ZA 915012B
Authority
ZA
South Africa
Prior art keywords
addiction
substance abuse
treating substance
pyridopyrazine derivatives
derivatives
Prior art date
Application number
ZA915012A
Other languages
English (en)
Inventor
Gene Michael Bright
Michael Bright Gene
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA915012B publication Critical patent/ZA915012B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA915012A 1990-06-29 1991-06-28 Pyridopyrazine derivatives for treating substance abuse and addiction ZA915012B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1990/003708 WO1992000075A1 (en) 1990-06-29 1990-06-29 Pyridopyrazine derivatives for treating substance abuse and addiction

Publications (1)

Publication Number Publication Date
ZA915012B true ZA915012B (en) 1993-02-24

Family

ID=22220931

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA915012A ZA915012B (en) 1990-06-29 1991-06-28 Pyridopyrazine derivatives for treating substance abuse and addiction

Country Status (17)

Country Link
US (1) US5616585A (xx)
EP (1) EP0536173B1 (xx)
JP (1) JPH05507274A (xx)
KR (1) KR930701171A (xx)
AT (1) ATE116545T1 (xx)
AU (1) AU651977B2 (xx)
CA (1) CA2086335C (xx)
DE (1) DE69106516T2 (xx)
DK (1) DK0536173T3 (xx)
ES (1) ES2066447T3 (xx)
HU (1) HUT62797A (xx)
IE (1) IE64467B1 (xx)
IL (1) IL98588A (xx)
MY (1) MY106553A (xx)
NZ (1) NZ238750A (xx)
WO (2) WO1992000075A1 (xx)
ZA (1) ZA915012B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6231833B1 (en) 1999-08-05 2001-05-15 Pfizer Inc 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors
HN1999000146A (es) 1998-09-21 2000-11-11 Pfizer Prod Inc Agentes farmaceuticos para el tratamiento de la enfermedad de parkinson, adhd y microadenomas.
EP1177792A3 (en) * 2000-07-27 2002-10-23 Pfizer Products Inc. Dopamine D4 Ligands for the treatment of novelty-seeking disorders
UA110688C2 (uk) 2012-09-21 2016-01-25 Пфайзер Інк. Біциклічні піридинони
EP3253755B1 (en) 2015-02-03 2020-08-26 Pfizer Inc Novel cyclopropabenzofuranyl pyridopyrazinediones

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK144213C (da) * 1979-06-20 1982-06-21 H B Nielsen Hylster til garnspole
US4777173A (en) * 1987-03-25 1988-10-11 Bristol-Myers Company Method for treatment of alcohol abuse
DE3727879A1 (de) * 1987-08-21 1989-03-02 Troponwerke Gmbh & Co Kg Verwendung von 2-pyrimidinyl-1-piperazin-derivaten
DE3736974A1 (de) * 1987-10-31 1989-05-11 Troponwerke Gmbh & Co Kg Verwendung von 2-pyrimidinyl-1-piperazin-derivaten
IL91451A0 (en) * 1988-08-30 1990-04-29 Bristol Myers Co Pharmaceutical compositions comprising azapiron compounds and their use in the treatment of addiction
WO1990008148A1 (en) * 1989-01-23 1990-07-26 Pfizer Inc. Bis-aza-bicyclic anxiolytic agents

Also Published As

Publication number Publication date
DE69106516T2 (de) 1995-05-11
CA2086335C (en) 1996-01-02
WO1992000074A3 (en) 1992-03-05
WO1992000075A1 (en) 1992-01-09
AU651977B2 (en) 1994-08-11
EP0536173B1 (en) 1995-01-04
IL98588A0 (en) 1992-07-15
IE64467B1 (en) 1995-08-09
JPH05507274A (ja) 1993-10-21
IL98588A (en) 1995-06-29
IE912259A1 (en) 1992-01-01
NZ238750A (en) 1999-09-29
ATE116545T1 (de) 1995-01-15
WO1992000074A2 (en) 1992-01-09
HUT62797A (en) 1993-06-28
AU7909491A (en) 1992-01-23
HU9204138D0 (en) 1993-04-28
EP0536173A1 (en) 1993-04-14
KR930701171A (ko) 1993-06-11
CA2086335A1 (en) 1991-12-30
ES2066447T3 (es) 1995-03-01
US5616585A (en) 1997-04-01
DE69106516D1 (de) 1995-02-16
MY106553A (en) 1995-06-30
DK0536173T3 (da) 1995-05-01

Similar Documents

Publication Publication Date Title
MY104861A (en) Bis-aza-bicyclic anxiolytic agents.
AU544345B2 (en) Imidazo(1,2-a)pyridine derivatives
HUT61311A (en) Process for producing /1,2,4/triazolo/1,5-a//1,3,5/-traizine and pyrazolo/2,3-a//1,3,5/-triazine derivatives and pharmaceutical compositions comprising same as active ingredient
HK1005363A1 (en) Use of cgmp-phosphodiesterase inhibitors to treat impotence
MY123390A (en) Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives
BG98124A (en) Active pyrrole-(2,3-)pyridine derivatives
DK531089D0 (da) Bicycliske imidazolforbindelser til anvendelse ved behandling af hyperaldosteronisme
ZA915012B (en) Pyridopyrazine derivatives for treating substance abuse and addiction
DE3768978D1 (de) Pyrrolo(1,2-a)(4,1)benzoxazepine, verfahren zur ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie therapeutische verwendung.
DE59107405D1 (de) Ein Imidazobenzodiazepin zur Behandlung von Schlafstörungen
ES2062351T3 (es) Derivados de triazolo (4,5-c) piridina anticonvulsivos.
IT1250646B (it) Derivati di pirazolo (4,3-e)pirrolo(1,2-a)(1,4)diazepina ad attivita` antitumorale.
PT84275A (en) Process for the preparation of tetracyclic quinazolinones